DOI:
10.1055/s-00000009
American Journal of Perinatology
LinksClose Window
References
Stasi R.
Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.
Curr Opin Mol Ther 2010;
12 (06) 734-740
Access:
We do not assume any responsibility for the contents of the web pages of other providers.